NO20071139L - Farmasoytisk preparat med langvarig frigivelse omfattende venlafaxin - Google Patents
Farmasoytisk preparat med langvarig frigivelse omfattende venlafaxinInfo
- Publication number
- NO20071139L NO20071139L NO20071139A NO20071139A NO20071139L NO 20071139 L NO20071139 L NO 20071139L NO 20071139 A NO20071139 A NO 20071139A NO 20071139 A NO20071139 A NO 20071139A NO 20071139 L NO20071139 L NO 20071139L
- Authority
- NO
- Norway
- Prior art keywords
- venlafaxine
- pharmaceutical composition
- prolonged
- release pharmaceutical
- dispersion
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Abstract
Det er beskrevet en fremgangsmåte for fremstilling av et farmasøytisk preparat inneholdende venlafaxin eller et farmasøytisk akseptabelt salt derav, som omfatter trinnene med (1) fremstilling av en dispersjon av venlafaxin eller et venlafaxinsalt i et oppløsningsmiddel hvori venlafaxinet eller venlafaxinsaltene har en oppløselighet på mindre enn 25 g/l ved romtemperatur; (2) omdanning av dispersjonen fra trinn (1) til partikkelform; (3) belegging av partiklene oppnådd i trinn (2) med et lag av polymer med langvarig frigivelse, så vel som farmasøytiske preparater som kan oppnås ved denne fremgangsmåten.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004036641A DE102004036641A1 (de) | 2004-07-28 | 2004-07-28 | Verzögert freisetzende pharmazeutische Zusammensetzung, die Venlafaxin enthält |
PCT/EP2005/008149 WO2006010605A2 (en) | 2004-07-28 | 2005-07-27 | Sustained release pharmaceutical particulate composition comprising venlafaxine |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20071139L true NO20071139L (no) | 2007-02-28 |
Family
ID=35106687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20071139A NO20071139L (no) | 2004-07-28 | 2007-02-28 | Farmasoytisk preparat med langvarig frigivelse omfattende venlafaxin |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1778193B1 (no) |
AT (1) | ATE381925T1 (no) |
CY (1) | CY1107187T1 (no) |
DE (2) | DE102004036641A1 (no) |
DK (1) | DK1778193T3 (no) |
EA (1) | EA009957B1 (no) |
ES (1) | ES2299061T3 (no) |
HR (1) | HRP20080007T3 (no) |
NO (1) | NO20071139L (no) |
PL (1) | PL1778193T3 (no) |
PT (1) | PT1778193E (no) |
RS (1) | RS50572B (no) |
SI (1) | SI1778193T1 (no) |
UA (1) | UA83437C2 (no) |
WO (1) | WO2006010605A2 (no) |
ZA (1) | ZA200701554B (no) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10722458B2 (en) * | 2011-12-02 | 2020-07-28 | Pegasus Laboratories, Inc. | Amphipathic lipid-based sustained release compositions |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL146462A (en) * | 2001-11-13 | 2015-02-26 | Lycored Bio Ltd | Prolonged-release preparations containing as an active compound and analapaxin hydrochloride |
EP1474123A1 (en) * | 2002-01-03 | 2004-11-10 | LEK Pharmaceuticals D.D. | Controlled release pharmaceutical formulation containing venlafaxine |
US20060257482A1 (en) * | 2002-06-07 | 2006-11-16 | Patrik Kumar | Modified release, multiple unit drug delivery systems |
CA2507685A1 (en) * | 2002-11-28 | 2004-06-10 | Themis Laboratories Private Limited | Process for manufacturing sustained release microbeads containing venlafaxine hci |
-
2004
- 2004-07-28 DE DE102004036641A patent/DE102004036641A1/de not_active Withdrawn
-
2005
- 2005-07-27 PL PL05768606T patent/PL1778193T3/pl unknown
- 2005-07-27 UA UAA200700846A patent/UA83437C2/uk unknown
- 2005-07-27 DK DK05768606T patent/DK1778193T3/da active
- 2005-07-27 AT AT05768606T patent/ATE381925T1/de active
- 2005-07-27 EA EA200700159A patent/EA009957B1/ru not_active IP Right Cessation
- 2005-07-27 PT PT05768606T patent/PT1778193E/pt unknown
- 2005-07-27 RS RSP-2008/0116A patent/RS50572B/sr unknown
- 2005-07-27 WO PCT/EP2005/008149 patent/WO2006010605A2/en active Application Filing
- 2005-07-27 SI SI200530187T patent/SI1778193T1/sl unknown
- 2005-07-27 DE DE602005004033T patent/DE602005004033T2/de active Active
- 2005-07-27 ES ES05768606T patent/ES2299061T3/es active Active
- 2005-07-27 EP EP05768606A patent/EP1778193B1/en active Active
-
2007
- 2007-02-22 ZA ZA200701554A patent/ZA200701554B/en unknown
- 2007-02-28 NO NO20071139A patent/NO20071139L/no not_active Application Discontinuation
-
2008
- 2008-01-09 HR HR20080007T patent/HRP20080007T3/xx unknown
- 2008-02-13 CY CY20081100161T patent/CY1107187T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PL1778193T3 (pl) | 2008-05-30 |
ZA200701554B (en) | 2008-05-28 |
SI1778193T1 (sl) | 2008-06-30 |
DK1778193T3 (da) | 2008-02-04 |
HRP20080007T3 (en) | 2008-01-31 |
EP1778193A2 (en) | 2007-05-02 |
DE102004036641A1 (de) | 2006-03-23 |
ES2299061T3 (es) | 2008-05-16 |
WO2006010605A3 (en) | 2006-09-21 |
DE602005004033D1 (de) | 2008-02-07 |
ATE381925T1 (de) | 2008-01-15 |
UA83437C2 (uk) | 2008-07-10 |
WO2006010605A2 (en) | 2006-02-02 |
CY1107187T1 (el) | 2012-10-24 |
PT1778193E (pt) | 2008-03-10 |
RS50572B (sr) | 2010-05-07 |
EA200700159A1 (ru) | 2007-06-29 |
EA009957B1 (ru) | 2008-04-28 |
DE602005004033T2 (de) | 2009-01-02 |
EP1778193B1 (en) | 2007-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2007302683A5 (no) | ||
WO2009154777A3 (en) | Process for preparing and drying solid rasagiline base | |
NO20091501L (no) | Farmasoytiske sammensetninger | |
CA2476201A1 (en) | Modified release formulations of at least one form of tramadol | |
NO20064934L (no) | Fremgangsmate for fremstilling av et fast, farmasoytisk preparat | |
WO2008007152A3 (en) | Preparation of pharmaceutical formulations | |
MY150087A (en) | Composition and microsphere for controlled- release of exendin, and method of preparing the same | |
AR054114A1 (es) | Composiciones farmaceuticas que comprenden imatinib y un retardador de la liberacion | |
NO20070871L (no) | Multipartikkelformulering | |
WO2009080836A3 (en) | Macrocyclic indoles as hepatitis c virus inhibitors | |
WO2011077451A3 (en) | Controlled release pharmaceutical composition | |
WO2006089674A3 (en) | Tablets with improved drug substance dispersibility | |
TW200633964A (en) | Tetralin and indane derivatives and uses thereof | |
MX2009010890A (es) | Nuevo proceso para la fabricacion del compuesto de 2-hidroxi-3-[5-(morfolin-4-ilmetil)piridin-2-il]1h-indol-5-carbon itrilo 701. | |
WO2009080628A3 (en) | Kit comprising an alginate and a complexing agent in the form of a water-soluble salt | |
MX2008001560A (es) | Nuevos compuestos analogos de la camptotecina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
WO2009034431A3 (en) | Controlled-release dosage forms for varenicline | |
TW200621307A (en) | Solid dispersion composition of pranlukast with improved bioavailibility and the method of preparing the solid dispersion | |
WO2010001413A3 (en) | Sustained release pharmaceutical compositions comprising quetiapine | |
ATE528301T1 (de) | Verfahren zur herstellung von substituierten sulfoxidzusammensetzungen | |
WO2005084636A3 (en) | A process for the preparation of controlled-release pharmaceutical composition of metoprolol | |
WO2010046932A3 (en) | Extended release pharmaceutical composition of minocycline and process thereof | |
WO2010020799A3 (en) | Compositions for the treatment of neoplastic diseases | |
EP2551266A8 (en) | 2',2-dithiazol non-nucleoside compounds, preparation methods, pharmaceutical compositions and uses as hepatitis virus inhibitors thereof | |
WO2006127321A3 (en) | Formulations of suberoylanilide hydroxamic acid and methods for producing same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |